Evidence map›Paper›PMID 34658873›Full record

ArticleFrontiers in pharmacology2021

Evaluating the Therapeutic Mechanisms of Selected Active Compounds in

De-Wei Zhu, Qun Yu, Ji-Jia Sun, Yun-Hui Shen

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Review
  3. Unraveling the Core Components and Critical Targets ofCurrent pharmaceutical design · 2025
    Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Study on the Mechanism of Radix Astragali against Renal Aging Based on Network Pharmacology.Evidence-based complementary and alternative medicine : eCAM · 2022
    Article
  9. Article
  10. Identifying Active Substances and the Pharmacological Mechanism ofEvidence-based complementary and alternative medicine : eCAM · 2022
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

De-Wei ZhuSchool of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Qun YuSchool of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Ji-Jia SunSchool of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Yun-Hui ShenSchool of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Shanghai University of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pulmonary fibrosis, a common outcome of pulmonary interstitial disease of various different etiologies, is one of the most important causes of respiratory failure.

Indexed as

Houttuynia cordata Thunb.molecular mechanismnetwork pharmacologypulmonary fibrosissignaling pathway analysis

Identifiers

PMID34658873
PMCPMC8514782
OpenAlexW3202331891

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.